What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

What Is the Program?
How the Program Works
Who We Are
News & Resources
Contact

Search

Faits saillants de l’année 2019 du PDM (édition française)

June 24, 2020
Français
Français

These are the accomplishments of the Mectizan Donation Program and its partners in 2019.

MDP Annual Highlights 2019 (French)|MDP Annual Highlights 2019 (French)

Share This Post:

Facebook

Twitter

LinkedIn

Email

Print

Get Our Newsletter

Sign up for quarterly updates and breaking news

URL

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Please select your preferred language:(Required)

English

Français

Δ

The Mectizan Donation Program is an international program to eliminate river blindness and lymphatic filariasis (LF), primarily funded by Merck & Co., Inc., Rahway, N.J., U.S.A.,* with additional support from GSK. For LF, Mectizan® is co-administered with albendazole, which is donated by GSK. | *Merck is known as MSD outside the USA and Canada.

Get in Touch

mectizan@taskforce.org
Tel. 1-404-371-1460
Fax 1-404-371-1138
330 West Ponce de Leon Avenue | Decatur, Georgia 30030 | USA

What Is The Program?

Overview
History Of The Program
Lymphatic Filariasis
River Blindness
The Medicines
Where We Work

Quick Links

How the Program Works
News from MDP
Resources
Meet Our Partners
Disclaimer
Contact Us

Facebook Instagram Youtube Twitter Linkedin

© 2026 Mectizan Donation Program ®

See the Annual Highlights of 2025—our accomplishments of the past year and plans for the future.